Inventor · disambiguated record
Richard B. Sparks
Also filed as: SPARKS RICHARD B · SPARKS RICHARD BRUCE
73 granted patents·11 pending applications·1,688 citations·filing 1994–2024
99Inventor score
Top patents by PatentIndex Score
84 records- 0199US9938294B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2017·Granted Apr 10, 2018·24 cites·14 claims
- 0299US9624241B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2015·Granted Apr 18, 2017·27 cites·8 claims
- 0399US8445488B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2011·Granted May 21, 2013·98 cites·9 claims
- 0499US8053433B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitorsINCYTE CORP·Filed 2007·Granted Nov 8, 2011·107 cites·15 claims
- 0599US7335667B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitorsINCYTE CORP·Filed 2005·Granted Feb 26, 2008·149 cites·38 claims
- 0698US10464947B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2018·Granted Nov 5, 2019·17 cites·56 claims
- 0798US10376513B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2018·Granted Aug 13, 2019·12 cites·21 claims
- 0898US9527864B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2015·Granted Dec 27, 2016·31 cites·40 claims
- 0998US9090611B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jul 28, 2015·60 cites·32 claims
- 1098US8835423B2Azepine inhibitors of janus kinasesINCYTE CORP·Filed 2013·Granted Sep 16, 2014·71 cites·33 claims
- 1198US8741895B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitorsINCYTE CORP·Filed 2013·Granted Jun 3, 2014·84 cites·32 claims
- 1298US8088803B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseCOMBS ANDREW P·Filed 2009·Granted Jan 3, 2012·64 cites·30 claims
- 1397US11498926B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2020·Granted Nov 15, 2022·4 cites·73 claims
- 1497US10919912B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2019·Granted Feb 16, 2021·10 cites·29 claims
- 1597US10227359B2Tricyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2017·Granted Mar 12, 2019·20 cites·6 claims
- 1697US10138248B2Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitorsINCYTE CORP·Filed 2017·Granted Nov 27, 2018·36 cites·24 claims
- 1797US10092570B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2017·Granted Oct 9, 2018·17 cites·20 claims
- 1897US9834565B2Tricyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2016·Granted Dec 5, 2017·23 cites·6 claims
- 1997US9730939B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Aug 15, 2017·23 cites·7 claims
- 2097US9227985B2Tricyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2014·Granted Jan 5, 2016·40 cites·14 claims
- 2197US9096600B2N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitorsLI YUN-LONG·Filed 2011·Granted Aug 4, 2015·47 cites·28 claims
- 2297US8993605B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2014·Granted Mar 31, 2015·34 cites·15 claims
- 2397US8759359B2Substituted heteroaryl fused derivatives as PI3K inhibitorsCOMBS ANDREW P·Filed 2010·Granted Jun 24, 2014·64 cites·25 claims
- 2496US10472368B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2018·Granted Nov 12, 2019·12 cites·28 claims
- 2596US9815839B2N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitorsINCYTE CORP·Filed 2016·Granted Nov 14, 2017·20 cites·16 claims
- 2696US9527848B2N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Dec 27, 2016·25 cites·12 claims
- 2796US9320732B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2015·Granted Apr 26, 2016·14 cites·9 claims
- 2896US9290514B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2014·Granted Mar 22, 2016·33 cites·44 claims
- 2996US8822511B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2013·Granted Sep 2, 2014·24 cites·36 claims
- 3096US8563541B2Azepine inhibitors of Janus kinasesARVANITIS ARGYRIOS G·Filed 2012·Granted Oct 22, 2013·92 cites·44 claims
- 3195US11433071B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2020·Granted Sep 6, 2022·3 cites·20 claims
- 3295US11225486B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2020·Granted Jan 18, 2022·4 cites·51 claims
- 3395US10618910B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2019·Granted Apr 14, 2020·12 cites·15 claims
- 3495US9944646B2Bicyclic azaheterocyclobenzylamines as PI3K inhibitorsINCYTE CORP·Filed 2016·Granted Apr 17, 2018·16 cites·22 claims
- 3595US9789094B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2016·Granted Oct 17, 2017·11 cites·23 claims
- 3695US8796319B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseCOMBS ANDREW P·Filed 2011·Granted Aug 5, 2014·21 cites·68 claims
- 3794US10646492B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2019·Granted May 12, 2020·9 cites·5 claims
- 3894US10259818B2Bicyclic azaheterocyclobenzylamines as PI3K inhibitorsINCYTE CORP·Filed 2018·Granted Apr 16, 2019·12 cites·15 claims
- 3994US10034864B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2017·Granted Jul 31, 2018·8 cites·20 claims
- 4094US9580419B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitorsINCYTE CORP·Filed 2015·Granted Feb 28, 2017·10 cites·7 claims
- 4194US9309251B2Bicyclic azaheterocyclobenzylamines as PI3K inhibitorsINCYTE CORP·Filed 2013·Granted Apr 12, 2016·25 cites·29 claims
- 4293US11926630B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Mar 12, 2024·2 cites·2 claims
- 4393US10975088B2Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitorsINCYTE CORP·Filed 2019·Granted Apr 13, 2021·6 cites·13 claims
- 4493US10479795B2Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitorsINCYTE CORP·Filed 2018·Granted Nov 19, 2019·13 cites·45 claims
- 4593US9879010B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b] pyrimidin-5-yl-amines as Janus kinase inhibitorsINCYTE CORP·Filed 2017·Granted Jan 30, 2018·8 cites·15 claims
- 4692US10369137B21,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2018·Granted Aug 6, 2019·5 cites·4 claims
- 4792US9193721B2Fused derivatives as PI3Kδ inhibitorsCOMBS ANDREW P·Filed 2011·Granted Nov 24, 2015·26 cites·39 claims
- 4892US8951536B2N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2013·Granted Feb 10, 2015·25 cites·17 claims
- 4992US8377976B2N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2011·Granted Feb 19, 2013·24 cites·9 claims
- 5091US10653677B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2019·Granted May 19, 2020·4 cites·20 claims
Showing the top 50 of 84 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Richard B. Sparks files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →